Effect of 1,25(OH)2 Vitamin D3 analogs on differentiation induction and cytokine modulation in blasts from acute myeloid leukemia patients

Leukemia and Lymphoma

Volumn 45, Issue 10, 2004, Pages 2119-2126

  Srivastava, Maya D ^a   Ambrus, Julian L ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Acute myeloid leukemias; Cytokines; Differentiation; Interferons; Interleukins; Vitamin D3 and analogs

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; CYTOKINE; GLYCOPROTEIN P; INTERLEUKIN 6; INTERLEUKIN 8;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CALCIUM ABSORPTION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SPECIFICITY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYPERCALCEMIA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STRUCTURE ANALYSIS;

ACUTE DISEASE; CALCITRIOL; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE PRECURSOR CELLS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKEMIA, MYELOCYTIC, ACUTE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4544255868     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819032000159924     Document Type: Article

References (47)

1. Tenen, D.G. (2003) "Disruption of differentiation in human cancer: AML shows the way", Nature Reviews, 3, 89-101.
2. Gattei, V., Degan, M., Aldinucci, D., De Iuliis, A., Rossi, F.M., Mazzocco, F.T., et al. (1998) "Differential expression of the RET gene in human acute myeloid leukemia", Annals of Hematology, 77(5), 207-210.
3. Lococo, F., Zelant, A., Kimchi, A., Carducci, M., Gore, S.D. and Waxman, S. (2002) "Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond", Cancer Research, 62, 5618-5621.
4. Mauro, M.J. and Druker, B.J. (2001) "STI-571: Targeting BCR-ABL as therapy for CML", The Oncologist, 6, 233-238.
5. 3: An extraordinary potent inhibitor of leukemic cell growth in vitro", Blood, 84, 1960-1967.
6. 3 in prostate cancer", Molecular Cancer Therapeutics, 1, 667-677.
7. Hansen, C.M., Hansen, D., Holm, P.K. and Binderup, L. (2001) "Vitamin D compounds exert anti-apoptotic effects in human osteocarcinoma cells in vitro", Journal of Steroid Biochemistry and Molecular Biology, 77, 1-11.
8. 3) inhibits the growth of squamous cell carcinoma and down modulates p21(Waf 1/cip 1) in vitro and in vivo", Cancer Research, 59, 2644-2649.
9. 3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells", Blood, 97, 2427-2433.
10. 3 on the G1-S phase-controlling machinery", Molecular Endocrinology, 15, 1370-1380.
11. 3 in seven human prostatic carcinoma cell lines", Clinical Cancer Research, 1, 997-1003.
12. Srivastava, M.D., Ambrus, J.L. and Uskokovic, M.R. (1995) "Calcitriol analogs cause differentiation of neoplastic cells in culture", Research Communications in Molecular Pathology and Pharmacology, 88, 77-85.
13. 3 derivatives", Research Communications in Chemical Pathology and Pharmacology, 83, 115-123.
14. 3 is a potent antileukemic agent with low potential to cause hypercalcemia", Leukemia Research, 18, 453-463.
15. Zhou, J.Y., Norman, A.W., Lubert, M., Collins, E.D., Uskokovic, M.R. and Koeffler, H.P. (1989) "Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect of either intestinal calcium absorption or bone calcium mobilization", Blood, 74, 82-93.
16. Adorini, L. (2002) "Immunomodulatory effects of Vitamin D receptor ligands in autoimmune diseases", International Immunopharmacology, 2, 1017-1028.
17. 3 stimulates phosphorylation of IKBα and synergizes with TPA to induce nuclear translocation of NFKB during monocytic differentiation of NB4 leukemia cells", Experimental Cell Research, 272, 176-184.
18. Srivastava, M.D. (1995) Modulation of proinflammatory cytokine production by human hematopoietic cell lines. Ph.D. Thesis, State University of New York at Buffalo, USA 1995.
19. 3 and two of its analogs with lower calcemic activity", Research Communications in Chemical Pathology and Pharmacology, 83, 145-150.
20. Behringer, D., Schaufler, J., Kresin, V., Lubbert, M. and Lindemann, A. (2001) "Differentiation associated modulation of the cytokine and chemokine expression pattern in human myeloid cell lines", Leukemia Research, 25, 141-149.
21. 3. Involvement of NF-KB down regulation in transcriptional repression of the p40 gene", Journal of Clinical Investigation, 101, 252-262.
22. 3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-Kappa B mediated interleukin-8 gene expression", European Journal of Biochemistry, 250, 63-71.
23. Kang, S., Griffiths, C.E., Fancher, L., Hamilton, T.A. and Choi, J.H. (1998) "Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions", British Journal of Dermatology, 138, 77-83.
24. 3 receptor agonist", Blood, 96, 3188-3194.
25. 3 inhibits cytokine production by human blood monocytes at the posttranscriptional level", Cytokine, 4, 506-512.
26. 3 inhibits gamma interferon synthesis by normal human peripheral blood lumphocytes", Proceedings of the National Academy of Science, 84, 3385-3390.
27. 3 analog MC903 on secretion of interleukin-1 alpha (IL-1 alpha) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1)" , Journal of Dermatologic Science, 7, 24-31.
28. Yamada, S., Shimizu, M. and Yamamoto, K. (2003) "Structure-function relationships of Vitamin D including ligand recognition by the Vitamin D receptor", Medical Research Reviews, 23, 89-115.
29. 3", Cell Growth and Differentiation, 13, 27-38.
30. Danilenko, M., Wang, X. and Studzinski, G.P. (2001) "Carsonic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents", Journal of the National Cancer Institute, 93, 1224-1233.
31. 2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells", Leukemia, 16, 1519-1527.
32. Gullberg, U., Nilsson, E., Einhorn, E. and Olsson, I. (1985) "Combinations of interferon gamma and retinoic acid or 1-alpha, 25-dihydroxychole-calciferol induce differentiation of the human monoblast leukemia cell line U-937", Experimental Hematology, 13, 675-679.
33. 3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis", Steroids, 66, 327-337.
34. 3", British Journal of Haematology, 112, 315-326.
35. 3: Differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption", Cancer Research, 50, 6857-6864.
36. 3 dependent differentiation of HL-60 cells: a cDNA array study", British Journal of Haematology, 118, 1065-1070.
37. 3 treated HL-60 cells shows an incomplete molecular phenotypic conversion to monocytes", Cell Death and Differentiation, 9, 1185-1195.
38. Trayner, I.D., Bustorff, T., Etches, A.E., Mufti, G.J., Foss, Y. and Farzaneh, F. (1998) "Changes in antigen expression on differentiating HL-60 cells treated with dimethylsulphoxide, all-trans retinoic acid, α1, 25-dihydroxy-vitamin D, or 12-0-tetradecanoylphorbol-13-acetate", Leukemia Research, 22, 537-547.
39. Yamada, K., Honma, Y., Asahi, K.I., Sassa, T., Hino, K.I. and Tomoyasu, S. (2001) "Differentiation of human acute myeloid leukemia cells in primary culture in response to cotylenin A, a plant growth regulator", British Journal of Haematology, 114, 814-821.
40. Scheper, R.J., Bulte, J.W.M., Brakkee, J.G.P., Quak, J.J., Van der Schoot, E., Balm, A.J.M., et al. (1988) "Monoclonal antibody JSB-1 detects a highly conserved epitope on the p-glycoprotein associated with multi-drug resistance", International Journal of Cancer, 42, 389-394.
41. Al-alami, O., Sammons, J., Martin, J.H. and Hassan, H.T. (1998) "Divergent effect of taxol on proliferation, apoptosis and nitric oxide production in MHH225 CD34 positive and U-937 CD34 negative human leukemia cells", Leukemia Research, 22, 939-945.
42. Srivastava, M.D., Ambrus, J.L. and Srivastava, B.I.S. (1998) Cytokine production by normal and malignant human cell lines. In Proceedings of the 17th International Cancer Congress Rio de Janeiro, 1998, edited by M. Morales, R. Brentani and R. Bevilacqua. Pp 115-118. Bologna (Italy): Monduzzi Editions S.P.A.
43. Honma, Y. and Ishii, Y. (2002) "Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormones" , Leukemia and Lymphoma, 43(9), 1729-1735.
44. Bruserud, O. and Gjertsen, B.T. (2000) "New strategies for the treatment of acute myelogenous leukemia: differentiation induction-present use and future possibilities", Stem Cells, 18(3), 157-165.
45. Olsson, I., Bergh, G., Ehinger, M. and Gullberg, U. (1996) "Cell differentiation in acute myeloid leukemia", European Journal of Haematology, 57(1), 1-16.
46. Paul, C.C., Aly, E., Lehman, J.A., Page, S.M., Gomez-Cambronero, J., Ackerman, S.J., et al. (2000) "Human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes", Experimental Hematology, 28(12), 1373-1380.
47. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., et al. (1996) "A central role for Stat3 in IL-6 induced regulation of growth and differentiation in M1 leukemia cells", EMBO Journal, 15(14), 3651-3658.